Luminex Corporation | Biotechnology Engineering Company
Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

The Faces of Luminex: Victoria Gutierrez, Global Events

Successful trade shows and events require strong leadership to align tactics with the strategic initiatives of marketing and sales teams—and that’s where Victoria Gutierrez, Senior Manager of Global Events, comes in. The Texas State University ‭graduate and proud Bobcat joined Luminex in 2013 and has been bringing our event strategy to life ‭ever since. She can be spotted on the trade show floor at major Luminex events and often sporting some of the best pairs of heels in the room!‬‬

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

In case you missed it, a recent Luminex blog discusses the latest 𝘊. 𝘥𝘪𝘧𝘧𝘪𝘤𝘪𝘭𝘦 clinical practice guidelines and stu…
h J R
Don’t miss out on a chance to showcase your #research. Submit your poster abstract for #xMAPConnect Boston today:…
h J R

Latest News

August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results

July 13
Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018

June 13
Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay

May 18
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences

May 18
Luminex Corporation Declares Second Quarter Cash Dividend


xMAP® Connect Boston
September 18
Boston, MA

October 3-7
San Francisco, CA

AMP Annual Meeting
November 1-3
San Antonio, TX

xMAP® Connect Amsterdam
November 1-3
San Antonio, TX